Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
China
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality
Cancer center, Shanghai 411 hospital, China RongTong Medical Healthcare Group Co.Ltd./411 Hospital, Shanghai University, Shanghai, Shanghai Municipality
Department of Surgical Oncology, Fudan University Shanghai Cancer Center Minhang Branch Hospital, Shanghai, Shanghai Municipality
Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality